NASDAQ:LFCR Lifecore Biomedical Q1 2026 Earnings Results & Report $6.40 -0.02 (-0.23%) As of 01:07 PM Eastern This is a fair market value price provided by Massive. Learn more. Lifecore Biomedical beat analyst expectations on both earnings and revenue in its Q1 2026 results, released November 6, 2025. The company reported EPS of -$0.29 versus the -$0.30 consensus estimate, while revenue of $31.11 million topped the $26.68 million estimate by $4.43 million. Research:ProfileEarnings HistoryForecast Earnings Announcement Details QuarterQ1 2026Report DateNovember 6, 2025TimeAfter Market ClosesConference Call7:00 AM ET Lifecore Biomedical EPS ResultsActual EPS-$0.29Consensus EPS -$0.30Beat/MissBeat by +$0.01One Year Ago EPSN/AEPS Beat Rate2 of last 8 quartersLifecore Biomedical Revenue ResultsActual Revenue$31.11 millionExpected Revenue$26.68 millionBeat/MissBeat by +$4.43 millionYoY Revenue GrowthN/AConference Call ResourcesQuarterly Report (10-Q)Earnings HistoryCompany ProfilePowered by Earnings DocumentsQuarterly report(10-Q) Lifecore Biomedical Q1 2026 Earnings FAQ Did Lifecore Biomedical beat earnings estimates for Q1 2026? Lifecore Biomedical (NASDAQ:LFCR) reported earnings of -$0.29 per share for Q1 2026, beating the consensus estimate of -$0.30. The report was announced on Thursday, November 6, 2025. What was Lifecore Biomedical's revenue for Q1 2026? Lifecore Biomedical reported revenue of $31.11 million for Q1 2026, against a consensus estimate of $26.68 million. Lifecore Biomedical Earnings HeadlinesLifecore Biomedical Inc.November 12, 2026 | marketwatch.comBRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: ADT Inc. (NYSE – ADT), RXO Inc. (NYSE – RXO), PTC Inc. (Nasdaq – PTC), Lifecore Biomedical, Inc. (Nasdaq – LFCR)November 11, 2026 | globenewswire.comI'm handing you this stock todayElon doesn't own the chip inside his Teslas or Starlink dishes. He licenses it from one little known public company. Now he's planning 1,000,000 AI satellites in orbit, and every one could pay this company a royalty. Analyst Dylan says the window to get in closes around December 8th, before new money floods into the buildout.November 17 at 1:00 AM | Behind the Markets (Ad)Lifecore's Q3 Loss Widens To $40 Mln As New PPQ Contract GainedNovember 5, 2026 | rttnews.comLifecore Biomedical Reports Financial Results for the Third Quarter Ended September 30, 2026, and Provides Corporate UpdateNovember 4, 2026 | markets.businessinsider.comLifecore Biomedical Reports Financial Results for the Third Quarter Ended September 30, 2026, and Provides Corporate UpdateNovember 4, 2026 | globenewswire.comSee More Lifecore Biomedical Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Lifecore Biomedical? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Lifecore Biomedical and other key companies, straight to your email. Email Address About Lifecore BiomedicalLifecore Biomedical (NASDAQ:LFCR) is a contract development and manufacturing organization (CDMO) focused on sterile injectable pharmaceutical products. The company works with customers on product development, formulation, analytical testing, regulatory support and commercial-scale manufacturing, including fill-finish services. Lifecore also develops and manufactures hyaluronic acid, a biopolymer used in medical products and other applications. Its capabilities support products in areas such as ophthalmology and orthopedics, as well as pharmaceutical and veterinary uses. Based in Chaska, Minnesota, Lifecore serves pharmaceutical and medical technology companies in the United States and internationally. The business has a history in hyaluronic acid production and has expanded its role as a CDMO serving customers from development through commercial manufacturing.View Lifecore Biomedical ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Amazon’s Black Friday Rush Could Kick Off a Holiday Season That Defines Its YearThe Next Nuclear Opportunity May Be in Fuel, Not Reactors: 3 Stocks to WatchTyson Foods' Earnings Beat Hides a Warning for Consumer Staples Dividend InvestorsMongoDB's Biggest Advantage May Be GitLab's Biggest WeaknessMicrosoft's Outage Barely Moved Its Stock, But a Bigger Risk May Be BuildingTyson Foods' 10% Surge Puts a Breakout in Sight, But Wall Street Remains CautiousOndas Is Building a Defense Growth Engine, But Can It Deliver on Its Backlog? Upcoming Earnings Lowe's Companies (11/18/2026)TJX Companies (11/18/2026)Target (11/18/2026)Palo Alto Networks (11/18/2026)NetEase (11/19/2026)Alibaba Group (11/19/2026)PDD (11/19/2026)Ross Stores (11/19/2026)Walmart (11/19/2026)Intuit (11/19/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.